Page 3 - Daniel Aletaha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel aletaha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Aletaha Today - Breaking & Trending Today

European Project set to tackle RA through coordinated efforts

A new European consortium with aims to discover new ways to maximise the impact of prescription drugs for patients suffering from Rheumatoid Arthritis, has welcomed industry partner Daman, a digital healthcare company based in Copenhagen, Denmark. Click to read more. ....

Daniel Aletaha , Peuropean League Against Rheumatism , University Of Vienna , Rheumatoid Arthritis , Medical University ,

Effective New Drug Could Expand Treatment Options for Rheumatoid Arthritis

In its final clinical trial, a new drug for treating the autoimmune disease rheumatoid arthritis has proved to be at least as effective as the current "gold standard" treatment. This opens up new treatment options for affected patients. ....

United States , Daniel Aletaha , Josef Smolen , Division Of Rheumatology , University Hospital Vienna , Department Of Medicine , Head Of The Division Rheumatology , Meduni Vienna , New England Journal , University Hospital ,

Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

Region Flamande , United Kingdom , Northern Ireland , Great Britain , Robin Besuyen , Franziska Matzkies , Alena Pechonkina , Yoshiya Tanaka , Asma Melaine , Hendrik Schulze Koops , Jasper Broen , Pieter Jan Stiers , James Galloway , Katrien Van Beneden , Paul Emery , Anne Tournadre , Thijs Hendrikx , Tatsuya Atsumi , Van Gijsel , Sander Strengholt , Ineke Seghers , Udo Lendl , Bernardg Combe , Patrick Durez , Mayah Buch , Gerd Burmester ,

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Patients under immunosuppressive therapy, who do not respond to primary COVID-19 vaccination, have an increased risk for severe COVID-19 disease courses. Until now, it was not clear whether those patients at risk can benefit from an additional booster vaccination. ....

Michael Bonelli , Daniel Aletaha , Emily Henderson , World Health Organization , Australian Technical Advisory Group On Immunization , Meduni Vienna , First Author , Australian Technical Advisory Group , Covid 19 , Immune Response ,

Third Vaccine Dose May Protect Those With Autoimmune Diseases

As Michael Bonelli, senior author of the Vienna study, explains: “B cells constitute an important cell population for the development of antibodies. We were able to show that more than 50% of patients receiving B-cell-depleting treatment with rituximab still develop antibodies to SARS-CoV-2 [Covid-19], and that there is potentially additional protection via a cellular immune response.”
This underscores the importance of vaccinating immunosuppressed patients against Covid, Bonelli said, while his colleague Daniel Aletaha, head of the university’s division of rheumatology, said they also showed that a third vaccination is sometimes needed for people with autoimmune disease.
“The findings from this study formed the basis for a now completed randomised booster vaccination study, which investigated whether the group of patients receiving rituximab treatment who were unable to produce antibodies following standard vaccination can develop humoral or cellular immunity if g ....

United Kingdom , Michael Bonelli , Daniel Aletaha , Cambridge University , Committee On Vaccination , Public Health England , University Of Vienna , Medical University , Freedom Day , Joint Committee , ஒன்றுபட்டது கிஂக்டம் , மைக்கேல் போனெல்லி , கேம்பிரிட்ஜ் பல்கலைக்கழகம் , குழு ஆன் தடுப்பூசி , பொது ஆரோக்கியம் இங்கிலாந்து , பல்கலைக்கழகம் ஆஃப் வியன்னா , மருத்துவ பல்கலைக்கழகம் , கூட்டு குழு ,